Top 10 Companies in the Infant Bifidobacterium Powder Market (2026): Market Leaders Powering Global Infant Nutrition

MARKET INSIGHTS

Global Infant Bifidobacterium Powder Market size was valued at USD 109.7 million in 2025 and is projected to reach USD 142.8 million by 2034, exhibiting a CAGR of 3.8% during the forecast period.

Infant Bifidobacterium Powder is a specialized probiotic supplement designed to support the developing gut microbiome of newborns and infants. Bifidobacterium strains, particularly Bifidobacterium infantis, are among the most prevalent and beneficial bacteria in a healthy infant’s gut, playing a crucial role in nutrient absorption, immune system development, and protection against pathogens. These powders are formulated for easy addition to breast milk, formula, or soft foods, providing a convenient way for parents to administer probiotics. The primary strains used include B. infantis, B. breve, B. longum, and B. bifidum, each selected for their specific health benefits and compatibility with an infant’s delicate digestive system.

The market growth is primarily fueled by increasing parental awareness of pediatric gut health and the proven benefits of probiotics in managing conditions like colic, diarrhea, and eczema. A growing focus on preventive healthcare, coupled with rising disposable income in emerging economies, is encouraging the adoption of specialized infant nutrition products. Furthermore, advancements in probiotic stabilization technologies that ensure viable bacteria reach the infant’s gut are enhancing product efficacy. Key market players are actively expanding their portfolios through innovation, such as the development of combination products that include prebiotics (synbiotics). Companies like Chr. Hansen, DuPont, and BioGaia are leading the market with extensive research and strategic initiatives aimed at capturing a larger share of this growing segment.

Infant Bifidobacterium Powder Market – View in Detailed Research Report

Top 10 Companies in the Infant Bifidobacterium Powder Market (2026)

1. International Flavors & Fragrances Inc. (IFF)

Headquarters: New York, United States

Key Offering: Infant Bifidobacterium Lactis HN019 powder, integrated into infant formulas and dietary supplements.

IFF has leveraged its global supply chain and cGMP manufacturing to deliver high‑purity probiotic powders that meet stringent infant safety standards. The company’s focus on research‑driven strain selection has positioned it as a preferred supplier for leading infant formula manufacturers worldwide.

Sustainability & Growth Initiatives:

• Investment in advanced fermentation technologies to increase strain viability.
• Partnerships with pediatric research institutions to validate health claims.
• Expansion of distribution through online retail and specialty health stores.

2. Chr. Hansen Holding A/S

Headquarters: Hørsholm, Denmark

Key Offering: BB‑12® probiotic powder, formulated for infant nutrition and fortified dairy products.

Chr. Hansen’s BB‑12® is one of the most clinically studied Bifidobacterium lactis strains, offering proven benefits for immune support and gut barrier function in infants.

Sustainability & Growth Initiatives:

• Expansion of synbiotic product line with galacto‑oligosaccharides (GOS).
• Strategic acquisitions of niche probiotic developers.
• Commitment to 100% renewable energy in manufacturing plants.

3. Lallemand Inc.

Headquarters: Montreal, Canada

Key Offering: Bifidobacterium breve and Bifidobacterium longum powders for infant dietary supplements.

Lallemand focuses on high‑purity, GMP‑grade probiotics with robust clinical evidence for infant gut health.

Sustainability & Growth Initiatives:

• Development of freeze‑dry technology to enhance shelf life.
• Collaboration with academic institutions on infant microbiome studies.
• Reduction of carbon footprint through optimized logistics.

4. BioGaia AB

Headquarters: Stockholm, Sweden

Key Offering: Lactic acid bacteria and Bifidobacterium infantis drops and powders for infant care.

BioGaia’s probiotic formulations are backed by strong safety data and are widely recommended by pediatricians.

Sustainability & Growth Initiatives:

• Use of biodegradable packaging materials.
• Investment in clinical trials for allergy prevention.
• Expansion into emerging markets through local partnerships.

5. Probi AB

Headquarters: Stockholm, Sweden

Key Offering: Bifidobacterium lactis HN019 and multi‑strain blends for infant nutrition.

Probi’s focus on strain‑specific health claims drives product differentiation in a crowded market.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling systems in production.
• Research into personalized probiotic solutions.
• Strategic alliances with global infant formula manufacturers.

6. Biosearch Life

Headquarters: Barcelona, Spain

Key Offering: High‑purity Bifidobacterium strains for B2B customers in infant nutrition.

Biosearch Life supplies scientifically validated ingredients to companies developing infant probiotic products.

Sustainability & Growth Initiatives:

• Adoption of ISO 14001 environmental management.
• Development of low‑oxygen packaging to preserve viability.
• Expansion of product portfolio to include prebiotic fibers.

7. Morinaga Milk Industry Co., Ltd.

Headquarters: Tokyo, Japan

Key Offering: B. longum BB536 powder for infant formula and dairy products.

Morinaga leverages its dairy expertise to integrate probiotics into high‑quality infant foods.

Sustainability & Growth Initiatives:

• Use of renewable energy in dairy processing.
• Partnerships with universities for gut microbiome research.
• Launch of fortified infant nutrition lines.

8. SYNBIO TECH INC.

Headquarters: Taipei, Taiwan

Key Offering: Bifidobacterium infantis and B. lactis blends for infant dietary supplements.

SYNBIO TECH focuses on high‑viability strains and advanced encapsulation technologies.

Sustainability & Growth Initiatives:

• Development of eco‑friendly packaging solutions.
• Collaboration with local health authorities for product safety.
• Expansion of e‑commerce distribution channels.

9. Bioflag

Headquarters: Shanghai, China

Key Offering: Bifidobacterium lactis and B. longum powders for infant nutrition.

Bioflag is rapidly scaling production capacity to meet growing demand in Asia‑Pacific.

Sustainability & Growth Initiatives:

• Implementation of lean manufacturing processes.
• Investment in local clinical trials for infant health.
• Partnerships with regional distributors.

10. DuPont (Nutrition & Biosciences division, now part of IFF)

Headquarters: Wilmington, United States

Key Offering: Bifidobacterium lactis HN019 powder for infant formula and dietary supplements.

DuPont’s HN019 strain is supported by extensive clinical data and is a trusted ingredient in many infant nutrition products.

Sustainability & Growth Initiatives:

• Investment in next‑generation fermentation platforms.
• Collaboration with global pediatric research networks.
• Commitment to 50% reduction in CO₂ emissions by 2030.

Download FREE Sample Report

Get Full Report

OUTLOOK

Over the next decade, the Infant Bifidobacterium Powder market is expected to consolidate around a few leading players that combine robust scientific evidence with scalable manufacturing and global distribution. Regulatory frameworks in key markets will continue to evolve, encouraging higher quality standards and fostering consumer trust. The shift toward personalized nutrition and value‑added formulations, such as synbiotics fortified with vitamins and minerals, will drive premium pricing and higher profit margins.

FUTURE TRENDS

The industry will see accelerated innovation in strain‑specific research, especially targeting immune modulation and allergy prevention. Digital health integration—through mobile apps that track infant gut health—will enable real‑time monitoring and tailored probiotic dosing. Moreover, expanding e‑commerce platforms and direct‑to‑consumer channels will broaden market reach, particularly in emerging economies where traditional retail penetration remains limited. Finally, sustainability will become a key differentiator, with companies investing in biodegradable packaging, renewable energy, and carbon‑neutral manufacturing to meet the expectations of environmentally conscious parents.